[Question 4. What diagnostic and therapeutic strategies in glucose metabolism disorders in the course of cystic fibrosis? Diabetes and cystic fibrosis: physiopathology and diagnostic criteria for glucose metabolism disorders].
Mosnier-Pudar
H
H
Service des maladies endocrines et métaboliques, hôpital Cochin, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France.
D003550:Cystic Fibrosis / Q000150:complications* / Q000503:physiopathology*; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D003937:Diagnosis, Differential; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D005947:Glucose